Investigating the effect of migrafar (Tanacetum parthenium) on migraine pain in children are treating with amitriptyline

Determining the effect of migrafar on migraine pain in children treated with emitriptyline

The clinical trial has a control group, one blind, randomly divided on 25 patients, randomly divided from A and B cards for randomization. First, it is numbered on paper according to the size of the sample from 1 to 50. Then two groups are randomly created with random elicitation software equal to the sample size and the generated numbers are placed in two study groups. Then, each person entering the study will take a card from the box and depending on the selected card, will be placed in the specified pawn.

Outpatients referred to Imam Ali (AS) Shahrekord Clinic, who were visited by the children's neurology department in 1400-1401 and diagnosed with mild to moderate migraine, are studied in order to evaluate the effect of Migrafar capsules.

Definitive diagnosis of migraine headache Mild to moderate headache intensity Not taking any other medicine for headache

Intervention group: recipient of standard drug Amirtriptyline along with Migrafar capsule Control group: recipient of the standard drug Amirtriptyline along with placebo (which is prepared and provided by Nutekfar pharmaceutical company)

The amount of headache-quality of sleep

The randomization will be simple. The randomization unit is individual. First, number the size of the sample from 1 to 50 on the paper (the number of papers is equal to 50 and they will be numbered from 1 to 50) and We put these papers in a box. With random allocation software, the members of the sample are divided into two groups, equal to the sample size and randomly in groups. Also, the software randomly generates numbers that will represent the studied group of people. Software address: https://random-allocation-software.software.informer.com/2.0/ Each person who enters the study randomly draws a number from the box and will be studied in one of two groups according to the number he/she takes out of the box. (The numbers inside the box are divided into two groups by the software. And that means, for example, the software has determined that the number 6 should enter the second group, when the subject selects the number 6 from the box, it will enter the second group)

Our study will be a one-sided blind study. In this study, the parents and children receiving the medicine will not know about the type of medicine received. The researcher and other people will have complete knowledge about the prescription drugs for each group. Also, the statistical analyst will also He will be aware of the groups and type of medicine received.

To share the data and documents of this research, only the information related to the main outcome will be shared. Also, files that can be published and do not violate people's privacy will be published.

The access period will start 6 months after the results are published.

Our data will only be available to researchers working in academic and scientific institutions

If there are conditions, all our data will be shared except personal information of people. The use of our data will only be allowed for similar research and review of our data by other researchers. All those who work in universities and scientific centers and decide to conduct similar research or check the accuracy of our data can access our data.

In order to receive information, all eligible people can collect data by referring to the person in charge of the project. The contact methods are the email address mehdi.sadeghi.68@gmail.com or the contact number 009891103122195.

To receive information after sending the request, the requests will be reviewed within 10 days. If the above conditions are met, the information will be sent to the provided email within 30 days at most.